Yi-Ming Chen is currently the director of the Division of Translational Medicine in the Department of Medical Research, Taichung Veterans General Hospital, Taiwan. Since 2009, he has worked as an attending physician at the Division of Allergy, Immunology and Rheumatology at the same institute. He has also served as a board member of the Chinese Society of Immunology since 2018. He studied at the School of Medicine at National Yang-Ming University in Taipei, Taiwan, attaining his MD qualification in 2002. He received his PhD from the Institute of Clinical Medicine at National Yang-Ming University in Taipei in 2014. In 2017, he was nominated as the Taiwanese representative of APLAR and a Young Rheumatologist Ambassador. From 2016 to 2018, he was appointed as the secretary general of the Taiwan Rheumatology Association. From 2019 to 2020, he worked as an exchange scholar at the Bioinformatics Section, National Institute of Neurological Disorder and Stroke, National Institutes of Health, USA. Yi-Ming Chen has authored or coauthored more than 100 papers published in international peer-reviewed journals. His expertise is in rheumatology, immunology, molecular biology, and medical genetics. His main research interests are the safety of biological treatment for autoimmune diseases, signal transduction in rheumatology, immunology, and genetic medicine.